An innovative project by ACTI-MENU, made possible with the support of
Santé des Populations and funding from AstraZeneca
MONTREAL, Oct. 3, 2013 /CNW Telbec/ - ACTI-MENU is pleased to announce
the development of the Let's Discuss Health program, produced in
collaboration with Drs. Marie-Thérèse Lussier and Claude Richard of the
Primary Care Research Team at the CSSS de Laval. Scheduled to launch in
September 2014 after nearly two years in development, this innovative
project is funded by the Santé des Populations program, with a $500,000
investment by AstraZeneca.
Let's Discuss Health will promote effective cooperation between patients
and healthcare professionals, including physicians, nurses, and
pharmacists. The program will focus on better communication between all
parties to encourage quality interactions, optimize the time spent in
consultations, and help patients self-manage their diseases.
Louis Gagnon, M.D., co-president and founder of ACTI-MENU, a social
enterprise dedicated to promoting health and healthy lifestyles, as
well as the prevention and management of chronic diseases, says, "One
of the program's greatest strengths is that it's aimed at both patients
and healthcare professionals. On the one hand, we strive to support
patients so that they play an active role in consultations and assume
responsibility for their own health. On the other hand, we strive to
equip professionals so that they can meet their patients' needs and
ascertain their understanding and motivation. Let's Discuss Health encourages us to view patients and their physicians as partners."
Guy Desrosiers, general manager of ACTI-MENU, says, "ACTI-MENU is
excited to bring the Let's Discuss Health program to fruition, with the
support of Santé des Populations and AstraZeneca. The program is an
inspiring example of the commitment of private companies who want to
support patients and healthcare providers to help improve the health of
A program centred on training
Let's Discuss Health will feature a website, training modules, and free
online interactive tools. The website will also include downloadable
documents to provide information and guidance to patients and
The professional training module, which implements recommendations from
the Chronic Care Model, is aimed at optimizing patient interactions and helping professionals
adapt their communicative approach to improve patient outcomes.
Patients, for their part, will learn how to develop their communication
skills, prepare for check-ups, and get the most out of their meetings
with healthcare professionals.
Healthcare professionals can also earn continuing education credits,
granted by Médecins francophones du Canada.
"Until now," says Marie-Thérèse Lussier, M.D., "few chronic disease
management programs have tried to improve communication between
patients and healthcare professionals. Our program will include
practical tools for consultations with patients dealing with
comorbidity, a growing clinical reality that complicates the
relationship for both parties. By encouraging patients to get involved
in managing their diseases and promoting better cooperation with
caregivers, we are helping to improve the quality of primary care and
ACTI‐MENU is a social enterprise owned by foundations associated with
the Montreal Heart Institute, the Centre ÉPIC, and the Hôpital
Maisonneuve‐Rosemont. Its mission is to help individuals take an active
role in their health. Founded in 1988, ACTI-MENU is dedicated
exclusively to promoting health and healthy lifestyles, as well as the
prevention and management of chronic diseases.
ACTI-MENU is behind well-known campaigns such as the 5/30 Health and Wellness Challenge, the Quit to Win! Challenge, and Smoke‐Free Family that are geared toward the general public, municipalities, and
families. ACTI-MENU also implements health-promotion programs in the
workplace and produces publications and other patient information tools
for the clinical setting. For more information, visit actimenu.ca.
ACTI-MENU received the Healthy Enterprise - Elite certification from the
Bureau de normalisation du Québec (BNQ).
About Santé des Populations
The goal of the Santé des Populations program is to foster financial support for innovative projects from
across Quebec, developed by both public and community-based agencies,
for the management of care and services for chronic disease. Santé des
Populations hopes to encourage the sharing and development of Quebec
expertise in this field to optimize the quality of life of those who
have, or are at risk of, one or more chronic diseases, and of the
population as a whole. The Santé des Populations program is funded by
pharmaceutical companies, including AstraZeneca.
About AstraZeneca Canada
AstraZeneca is a global, innovation-driven biopharmaceutical business
that focuses on the discovery, development, and commercialisation of
prescription medicines, primarily for the treatment of cardiovascular,
metabolic, respiratory, inflammation, autoimmune, oncology, infection,
and neuroscience diseases. AstraZeneca operates in over 100 countries
and its innovative medicines are used by millions of patients
AstraZeneca Canada recently announced the donation of $35 million to the
NEOMED Institute. This donation includes land, a state-of-the-art
research facility, and leading-edge laboratory equipment. It also
includes the donation of intellectual property to three AstraZeneca
pain molecules and projects, as well as $5 million to support the
activities of the Institute. AstraZeneca's Canadian headquarters are
located in Mississauga, Ontario. For more information please visit: astrazeneca.com.
For further information:
Information and interviews:
Media Relations and Social Media Advisor
514 985‐2466, ext. 255